Alzheimer’s Disease (AD) is a worldwide problem that does not yet have a clear solution. Although new treatments are starting to emerge, they do not work for every patient. The reason is likely individual difference in the specific, molecular, causes of AD. In our project, we will explore an innovative method to classify AD patients and guide personalized treatment selection and treatment development. We hope this custom approach allows successfully treating more AD cases.
Biotech Booster and CSL have taken a significant step towards accelerating biotech innovations. The organizations signed a collaboration agreement to
Congratulations to Fleur van Eeden, Dr. Brigit van Brenk, and Dr. Carina Nieuwenweg for receiving a personal grant by the
Meet EXIT071, part of the first batch of Proof-of-Concept projects that joined the Biotech Booster program after the round of
T-Guard is a Biotech Booster project addressing a significant unmet medical need in systemic sclerosis, a severe and debilitating autoimmune
In this series “Meet the people behind Biotech Booster” we introduce you to the passionate people who are involved in
On March 13th we had the privilege of hosting the second Annual Event of Biotech Booster at the AFAS Theater
Biotech Booster helps us through funding and by providing us with a network to validate where we can make the best impact with our new analysis device.
Constellate
What we look forward to most is leveraging the extraordinary network of Biotech Booster that we need to get foot in the market, get know-how, and understanding the competitive field which is necessary for setting up successful operations.
ProteoT
Receive monthly updates about our community!
